On November 8, 2018 Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, reported that it will participate in the following upcoming healthcare conferences in November (Press release, Intellia Therapeutics, NOV 8, 2018, View Source [SID1234531157]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Tuesday, November 13, 2018
Credit Suisse Healthcare Conference
Location: Scottsdale, Arizona
Time: 2:50pm MT (4:50pm ET)

Thursday, November 15, 2018
Jefferies London Healthcare Conference
Location: London, United Kingdom
Time: 12:40pm GMT (7:40am ET)

Thursday, November 29, 2018
Barclays Gene Editing and Gene Therapy Summit
Location: New York, NY
Time: 3:00pm ET

A live webcast of Intellia’s presentations at the Credit Suisse Healthcare Conference and Jefferies London Healthcare Conference will be accessible through the Events and Presentations page of the Investor Relations section of the company’s website at www.intelliatx.com. To access the webcasts, please log on to the Intellia website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Intellia’s website for approximately 14 days following each conference.